B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy

Targeting B7-H3 over-expressed tumor cells with anti-B7-H3 monoclonal antibodies inhibits tumor growth. Here we demonstrated the expression of B7 family homologue 3 (B7-H3) in a wide range of human tumor cells and further investigated whether B7-H3 could be served as a target for T-cell mediated imm...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Ma, Juan, Ma, Pan, Zhao, Chenghai, Xue, Xin, Han, Huamin, Liu, Changzhen, Tao, Hua, Xiu, Weigang, Cai, Jia, Zhang, Man
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2016
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5045411/
https://ncbi.nlm.nih.gov/pubmed/27121051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8784
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak